Contact Waterloo Institute for Nanotechnology
Mike & Ophelia Lazaridis Quantum-Nano Centre, Room 3606
University of Waterloo
200 University Ave. W.
Waterloo, ON. N2L 3G1
+1 519 888 4567, ext.38654
Dr. Emmanuel Ho is currently an Associate Professor in the School of Pharmacy at the University of Waterloo. His current research program is focused on the development and characterization of innovative nanomedicines, medical devices and biomaterials for imaging, treatment, and prevention of diseases including HIV/AIDS, cancer, and chronic wounds. Dr. Ho’s research group is also interested in utilizing nanotechnology as an innovative tool for delineating the immunological and molecular mechanisms regulating disease pathogenesis.
Dr. Ho is the past President of the Canadian Chapter of the Controlled Release Society (CC-CRS), is currently an Associate Editor for the Journal of Pharmacy & Pharmaceutical Sciences, and was an invited speaker for the inaugural 2014 TEDx UManitoba event.
Dr. Ho is an international expert in nanomedicine and was awarded the 2015 Association of Faculties of Pharmacy of Canada (AFPC) New Investigator Research Award, the 2015 Gattefosse Canada / Canadian Society for Pharmaceutical Sciences (CSPS) Award in Lipid-Based Drug Delivery, the 2014 GlaxoSmithKline / CSPS Early Career Award, and the 2013 Rh Award for Excellence in Research (Interdisciplinary Category).
- CIHR/MSFHR Post-Doctoral Fellow, British Columbia Cancer Research Center
- Ph.D., University of Toronto
- Hons.B.Sc., University of Toronto
The HoResearchGroup uses an interdisciplinary approach to develop strategies for the imaging, treatment, and prevention of diseases. This involves the fabrication and characterization of innovative biomaterials for drug delivery systems such as nanoparticles, medical devices, biodegradable films, hydrogels, etc.
- Drug delivery and pharmaceutics
- Nanomedicine, medical devices, biomaterials
- 3D Printing, hot-melt injection molding
- HIV/AIDS, cancer, chronic wound healing
- Website: http://HoResearchGroup.com
- Self-assembled nanoparticles made from a new PEGylated poly(aspartic acid) graft copolymer for intravaginal delivery of poorly water-soluble drugs. Kim S, Traore YL, Lee JS, Kim JH, Ho EA, Liu S. J Biomater Sci Polym Ed. 2017 Dec;28(17):2082-2099. PMID: 28853638
- Development of antibody-modified chitosan nanoparticles for the targeted delivery of siRNA across the blood-brain barrier as a strategy for inhibiting HIV replication in astrocytes. Gu J, Al-Bayati K, Ho EA. Drug Deliv Transl Res. 2017 Aug;7(4):497-506. PMID: 28315051
- Reversibly pH-responsive polyurethane membranes for on-demand intravaginal drug delivery. Kim S, Chen Y, Ho EA, Liu S. Acta Biomater. 2017 Jan 1;47:100-112. PMID: 27717914
- Nanoparticles Encapsulated with LL37 and Serpin A1 Promotes Wound Healing and Synergistically Enhances Antibacterial Activity. Fumakia M, Ho EA. Mol Pharm. 2016 Jul 5;13(7):2318-31. PMID: 27182713
- Impact of Hydroxychloroquine-Loaded Polyurethane Intravaginal Rings on Lactobacilli. Traore YL, Chen Y, Bernier AM, Ho EA. Antimicrob Agents Chemother. 2015 Dec;59(12):7680-6. PMID: 26416871
- Biodegradable Film for the Targeted Delivery of siRNA-Loaded Nanoparticles to Vaginal Immune Cells. Gu J, Yang S, Ho EA. Mol Pharm. 2015 Aug 3;12(8):2889-903 PMID: 26099315
- Development of an Analytical Method for the Rapid Quantitation of Peptides Used in Microbicide Formulations. Chen Y, Yang S, Ho EA. Chromatographia. 2014;77(23-24):1713-1720. PMID: 25477555
- Development of polyether urethane intravaginal rings for the sustained delivery of hydroxychloroquine. Chen Y, Traore YL, Li A, Fowke KR, Ho EA. Drug Des Devel Ther. 2014 Oct 9;8:1801-15. PMID: 25336923